Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04164173 · ClinicalTrials.gov registry record · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
A NA study of Postoperative Complications and Pulmonary Disease, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 324
- Enrollment target
- 1
- Study location
NCT04164173: Recruiting NA study of Postoperative Complications and Pulmonary Disease, sponsored by University of Texas Southwestern Medical Center.
NCT04164173 is a NA study of Postoperative Complications and Pulmonary Disease that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 324 participants, below the 546-participant average among 20 other Postoperative Complications trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04164173, a NA study of Postoperative Complications and Pulmonary Disease, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 324 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation therapy provides better lung expansion and may improve lung recovery after surgery.
Primary Outcome
The postoperative changes in the Forced Expiratory Volume in one second (FEV1)/the Forced Vital Capacity (FVC) in microspirometry
Conditions Studied
Interventions
- DEVICE EzPAP
- DEVICE Metaneb
- DEVICE Intermittent Positive Pressure Breathing (IPPB)
Study Locations (1)
Texas
- UT Southwestern Clements University Hospital - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT04164173 shows while recruiting
NCT04164173 is an interventional study that assigns participants to a tested intervention. The registered 324 participants enrollment target is mid-sized for trials with a published cap, below the 546-participant average among 20 other Postoperative Complications trials with a reported enrollment target (41% lower).
The record links to 2 conditions, with Postoperative Complications appearing as the primary indexed condition, and to 3 interventions - of which EzPAP is the first listed.
NCT04164173 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04164173 about?
NCT04164173 is a clinical study titled "Hyperinflation Respiratory Therapies in Cardiac Surgery Patients". The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation the...
What is the current status of trial NCT04164173?
This trial is currently recruiting. It is a NA study. The enrollment target is 324 participants. The study started on 2020-06-15. Estimated completion is 2028-12-31.
What conditions does trial NCT04164173 study?
This clinical trial studies the following conditions: Postoperative Complications, Pulmonary Disease.
What interventions are being tested in trial NCT04164173?
The interventions under investigation include: EzPAP (DEVICE), Metaneb (DEVICE), Intermittent Positive Pressure Breathing (IPPB) (DEVICE).
Who is sponsoring clinical trial NCT04164173?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04164173 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04164173's enrollment target sits among peer trials
324 5th of 20 higher than 16 of 20 other Postoperative Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nutrition to Support Postoperative Recovery
RECRUITING · NA
-
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
RECRUITING · NA
-
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
RECRUITING · NA
-
The Impact of Prehabilitation
RECRUITING · NA
-
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
RECRUITING · NA
-
Postoperative VR for Recovery After Bariatric Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
- NCT05647772 · 324 participants · NA
Digital Therapeutics for Behavior Problems
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI